What's more, mutant activation of AKT was generated in a context of HDAC7 inhibition to fully demonstrate that HDAC7 promotes the malignant progression of ovarian cancer through the AKT/mTOR pathway. This evidence concerns the gene MTOR and ovarian carcinoma.